METTL3 and metabolic disease: To confirm the relationship between high expression level of Mettl3 and HFD-induced metabolic disorders, we specifically overexpressed Mettl3 in mouse liver by hepatocyte-targeted AAV8 [28] and hepatocyte-specific promoter (LP1) [29] (Figure S2A).